Pharmacology

Chemotherapy and Toxicology Practice Questions

20 free Chemotherapy and Toxicology practice questions for the USMLE Step 1, each with the correct answer and a detailed explanation. Open any question below, or take the full set as an interactive quiz.

Start Practice Quiz

Questions

All Chemotherapy and Toxicology questions

20 questions
  1. Q1. Which class of chemotherapy agents works by forming DNA crosslinks that prevent replication and transcription, acting in a cell-cycle–nonspecific manner?
  2. Q2. Which toxic effect is most characteristic of platinum-based agents like cisplatin or carboplatin?
  3. Q3. Which chemotherapy drug class mimics normal nucleotides to block DNA synthesis during S-phase?
  4. Q4. Which of the following is a major dose-limiting toxicity of many chemotherapy agents affecting rapidly dividing bone marrow cells?
  5. Q5. A patient develops hemorrhagic cystitis after chemotherapy with cyclophosphamide. Which metabolite is primarily responsible?
  6. Q6. Which chemotherapy drug class interferes with microtubule function, preventing mitosis by disrupting the mitotic spindle?
  7. Q7. Which of the following is a well-known cardiotoxic chemotherapy agent often limited by cumulative dose?
  8. Q8. Which anti-cancer drug class exerts its effect by inhibiting topoisomerase enzymes, thus preventing DNA unwinding and replication?
  9. Q9. Which adverse effect is most characteristic of bleomycin therapy?
  10. Q10. Which of the following statements regarding chemotherapy resistance is correct?
  11. Q11. Which organ system is especially vulnerable to toxic effects of chemotherapy due to high turnover of cells and drug metabolism?
  12. Q12. Which type of chemotherapy drug would be most effective during S-phase of the cell cycle?
  13. Q13. Which chemotherapy agent class can cause peripheral neuropathy due to microtubule disruption?
  14. Q14. Which of the following is a risk of long-term alkylating agent chemotherapy, even after client has recovered from initial treatment?
  15. Q15. Which antimetabolite is most likely to cause hepatotoxicity and requires careful monitoring of liver enzymes?
  16. Q16. Which chemotherapy agent is most likely to cause hepatotoxicity and requires careful monitoring of liver enzymes?
  17. Q17. Which chemotherapy drug is associated with acute cholinergic diarrhea due to its mechanism as a topoisomerase I inhibitor?
  18. Q18. Which feature is a reason for using combination chemotherapy regimens rather than monotherapy?
  19. Q19. Which chemotherapy agent class is derived from plant alkaloids and disrupts mitosis by stabilizing microtubules rather than preventing their assembly?
  20. Q20. Which chemotherapy agent is most likely to cause mucositis, alopecia, and bone marrow suppression shortly after administration?